MedPath

Borte Trust 3.5

Brand Name: Borte Trust 3.5

Generic Name: Bortezomib

Active
Registration Number

DRP-12665

Dosage Form

Lyophilized Powder for Injection (IV/SC)

Issuance Date

September 21, 2022

Expiry Date

September 21, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength3.5mg
Packaging10 mL Type I Clear Tubular Borosilicate Glass Vial with Bromobutyl Rubber Stopper and Light Blue Aluminum Seal and Flip-Off Cap x l's (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

BortezomibActive
Monograph: Bortezomib

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform